KEMADRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kemadrin, and when can generic versions of Kemadrin launch?
Kemadrin is a drug marketed by Monarch Pharms and is included in one NDA.
The generic ingredient in KEMADRIN is procyclidine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the procyclidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KEMADRIN?
- What are the global sales for KEMADRIN?
- What is Average Wholesale Price for KEMADRIN?
Summary for KEMADRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Patent Applications: | 2,690 |
| DailyMed Link: | KEMADRIN at DailyMed |
US Patents and Regulatory Information for KEMADRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Monarch Pharms | KEMADRIN | procyclidine hydrochloride | TABLET;ORAL | 009818-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Monarch Pharms | KEMADRIN | procyclidine hydrochloride | TABLET;ORAL | 009818-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
